Results 11 to 20 of about 7,454,476 (197)

Mast Cell Activation Disorders [PDF]

Medicina, 2021
Background and Objectives: Mast cell disorders comprise a wide spectrum of syndromes caused by mast cells’ degranulation with acute or chronic clinical manifestations.
Arianna Giannetti, Emanuele Filice, Carlo Caffarelli, Giampaolo Ricci, Andrea Pession   +4 more
doaj   +3 more sources

Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series [PDF]

J Pers Med, 2023
Mast cell activation syndrome (MCAS) is an immune disease with an estimated prevalence of 17%. Mast cell chemical mediators lead to heterogeneous multisystemic inflammatory and allergic manifestations.
Weinstock L, Nelson R, Blitshteyn S.
europepmc   +3 more sources

Mast cell activation syndrome. About a clinical case

Revista Alergia México, 2019
Background: Monoclonal mast cell activation syndrome is included in mast cell activation disorders in which, after a diagnostic process, it is not possible to meet the required criteria for a diagnosis of systemic mastocytosis.
Ricardo Cardona, Maria Angélica Muñoz-Ávila, Catalina Gómez-Henao, Susana Diez-Zuluaga, Kenny Mauricio Gálvez-Cárdenas   +4 more
doaj   +2 more sources

Mast cell activation syndrome: A new outlook [PDF]

Медицинская иммунология, 2023
Mast Cell Activation Syndrome (MCAS) is a severe relapsing disease requiring inpatient treatment, with clinical pattern including the features of anaphylaxis.
N. V. Mikryukova, N. M. Kalinina
doaj   +2 more sources

Idiopathic mast cell activation syndrome [PDF]

, 2022
BACKGROUND: Idiopathic mast cell activation syndrome (MCAS) is one of the causes for recurrent complaints. The diagnosis is sometimes delayed but also often made incorrectly.
van Wijk, Roy Gerth, van Daele, Paul L.A.; id_orcid, Hermans, Maud A.W., Oude Elberink, J. Hanneke N.G.   +3 more
core   +8 more sources

Idiopathic mast cell activation syndrome and radiation therapy: a case study, literature review, and discussion of mast cell disorders and radiotherapy [PDF]

Radiation Oncology, 2019
Background Mast Cell Activation Syndrome (MCAS) is classified as an idiopathic mast cell disorder where inconsistent or unknown triggers release inflammatory mediators and cause a constellation of symptoms.
Robin E. Landy, William C. Stross, Jackson M. May, Tasneem A. Kaleem, Timothy D. Malouff, Mark R. Waddle, Laura A. Vallow   +6 more
doaj   +2 more sources

Comparing histamine intolerance and non-clonal mast cell activation syndrome [PDF]

Intestinal Research, 2020
Nevio Cimolai
doaj   +2 more sources

The Clinical Relevance of Mast Cell Activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Diagnostics
Background/Objectives: Growing evidence suggests that mast cell activation (MCA) may contribute to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating disorder characterized by persistent fatigue and post-exertional malaise (PEM).
Johanna Rohrhofer, Lilian Ebner, Johannes Schweighardt, Michael Stingl, Eva Untersmayr   +4 more
doaj   +2 more sources

Central Role of Mast Cells in Mastocytosis, Hereditary α-Tryptasemia, Mast Cell Activation Syndrome, Urticaria, and Angioedema

European Medical Journal Allergy & Immunology, 2022
Mast cells are the central cells in the pathogenesis of many conditions that are associated with mediator release. New information is emerging about the role of mast cells in a number of conditions. This review summarises current knowledge on the topic.
Michael Rudenko
doaj   +1 more source

Mast cell activation syndrome and the link with long COVID

, 2022
Mast cells are innate immune cells found in connective tissues throughout the body, most prevalent at tissue-environment interfaces. They possess multiple cell-surface receptors which react to various stimuli and, after activation, release many mediators
Soumya Arun, Storan, A, Arun, S, Myers, B, Bethan Myers, Abbie Storan, Myers, Bethan   +6 more
core   +2 more sources